Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings

Detalles Bibliográficos
Autores principales: de Jong, Lisa A., Groeneveld, Jessie, Stevanovic, Jelena, Rila, Harrie, Tieleman, Robert G., Huisman, Menno V., Postma, Maarten J., van Hulst, Marinus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970364/
https://www.ncbi.nlm.nih.gov/pubmed/35358286
http://dx.doi.org/10.1371/journal.pone.0266625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970364/
https://www.ncbi.nlm.nih.gov/pubmed/35358286
http://dx.doi.org/10.1371/journal.pone.0266625

Ejemplares similares